STRIDE: Pivotal Study to Evaluate the Safety and Effectiveness of the CereVasc eShunt System in the Treatment of Normal Pressure Hydrocephalus

Grants and Contracts Details

StatusActive
Effective start/end date3/20/253/20/27

Funding

  • CereVasc Incorporated: $13,000.00